Grupo Fleury | Hospital Saha | Advent International Partnership
Grupo Fleury is one of Brazil's largest and most respected medical organizations, serving as the benchmark for diagnostic excellence and clinical innovation in Latin America for nearly a century. With a multi-billion dollar valuation and a robust presence across the healthcare continuum, the Group is characterized by its uncompromising technical standards and human-centric care.
Hospital Saha , a flagship surgical and clinical center in São Paulo, serves as the Group's primary laboratory for high-stakes innovation. By integrating specialized hospital care with Fleury's diagnostic powerhouse, Hospital Saha provides an elite, controlled environment for the deployment of the next generation of medical technology.
The modernization of our infrastructure is backed by significant capital investment from Advent International , one of the world's largest and most experienced global private equity firms. This US-based partnership provides the financial liquidity and global strategic expertise required to scale Hospital Saha's innovations from a local blueprint to a global standard. This alliance ensures that Project Omate is backed by the resources of a world-class financial powerhouse.
In the current "tech jungle" of digital health competition, Project Omate represents a definitive departure from reactive care. It is a proprietary Predictive Bio-Intelligence Layer designed to transition healthcare from episodic monitoring to a 24/7 continuous "Digital Guardian" model.
Current post-discharge care is reactive, relying on patient self-reporting. This leads to high readmission rates and missed early warning signs in cardiac and diabetic recovery. Omate shifts this to a proactive, data-driven model.